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This study investigated the development of a novel approach to surface characterization of drug poly-
morphism and the extension of the capabilities of this method to perform ‘real time’ in situ measure-
ments. This was achieved using diffuse reﬂectance visible (DRV) spectroscopy and dye deposition, using
the pH sensitive dye, thymol blue (TB). Two polymorphs, SFN-β and SFN-γ, of the drug substance sul-
fanilamide (SFN) were examined. The interaction of adsorbed dye with polymorphs showed different
behavior, and thus reported different DRV spectra. Consideration of the acid/base properties of the
morphological forms of the drug molecule provided a rationalization of the mechanism of differential
coloration by indicator dyes. The kinetics of the polymorphic transformation of SFN polymorphs was
monitored using treatment with TB dye and DRV spectroscopy. The thermally-induced transformation
ﬁtted a ﬁrst-order solid-state kinetic model (R2¼0.992), giving a rate constant of 2.43102 s1.
& 2016 Xi'an Jiaotong University. Production and hosting by Elsevier B.V. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Polymorphic transformations can have a signiﬁcant inﬂuence
on the processing and storage of crystalline powders. Change in
crystalline structure affects the therapeutic effectiveness and sta-
bility of drug products; therefore, the ability to monitor the effect
of process stages on drug polymorphic transformation is crucial in
drug manufacture [1]. The transformation from one polymorphic
form to another can be thermally, mechanically or moisture-
induced.
Solid-state phase (polymorphic) transformations are generally
based on overlapping mechanisms of nucleation, growth and im-
pingement [2,3]. Solid-state kinetic evaluation typically involves
modeling the fraction transformed as a function of time.
Eq. 1 represents a generic integral rate equation for solid-state
kinetics:
( ) = ( )g a kt 1
where g is a function of the extent of reaction, a is the fraction
of phase transformed or extent of growth of new phase, k is the
rate constant, and t is time. The kinetics of the phase transfor-
mation is heterogeneous in nature, which suggests that severalon and hosting by Elsevier B.V. Th
University.
itchell).factors affect the kinetics of transformation including activation
energy of nucleation and growth, difference in the crystal im-
perfections, particle size and particle morphology, and variation in
growth rate along crystallographic axes. These factors contribute
to the development of different models used in the characteriza-
tion of the kinetics of solid-state phase transformation resulting in
acceleratory, deceleratory, linear or sigmoidal shapes for their re-
spective isothermal α-time curves [3,4].
A variety of techniques have been employed to characterize the
kinetics of polymorphic transformation in situ. Examples include
near infrared spectroscopy (NIR) [5,6], vibrational spectroscopy
[7,8], powder X-ray diffraction (PXRD) [9] and temperature-con-
trolled simultaneous small/wide angle X-ray scattering [10]. Pre-
vious reports also include the study of the thermodynamics of the
conversion of sulfanilamide (SFN) polymorphs by energy dis-
persive X-ray diffraction [11]. Monitoring processes, especially by
in situ methods including diffuse reﬂectance visible (DRV) spec-
troscopy, offer a better understanding of the intrinsic properties of
systems, thus improving process control [12].
This study reports on a novel ‘real time’ method for monitoring
thermally induced conversion of polymorphs using DRV spectro-
scopy and kinetic evaluation of the generated data. Polymorphs of
SFN were examined. The two polymorphs (SFN-β and SFN-γ)
studied are enantiotropically related and the conversion of SFN-β
to SFN-γ can be induced at elevated temperatures. Although other
reports on the analysis of polymorphs include the use of NIR [5,6]is is an open access article under the CC BY-NC-ND license
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scopy as the technique of choice for this study. We have experi-
ence in using DRV spectroscopy for the differentiation of crystal-
line and amorphous forms of carbohydrate pharmaceutical ex-
cipients, and in this study, we explored the extension of the sen-
sitivity, simplicity of operation and ease of data analysis of this
technique to more complex active pharmaceutical ingredients.
Furthermore, initial attempts to monitor polymorphic inter-
conversion using Raman spectroscopy was proved ineffectively.Fig. 1. PXRD patterns for (A) SFN-β and (B) SFN-γ.2. Experimental
2.1 Chemicals and preparation
SFN-β was prepared by recrystallization in water. Commercial
sulfanilamide (499.0%) from Sigma Aldrich (Dorset, England) was
dissolved in hot water (at 100 °C) and left to cool to ambient
temperature (23.5 °C). SFN-β was ﬁltered under suction and dried
over calcium chloride in a desiccator. SFN-γ was obtained from
recrystallized SFN-β that was heated at 140 °C for 2 h. All poly-
morphs were stored in a desiccator over calcium chloride (0% RH)
prior to analysis to eliminate moisture-induced transformations.
2.2 Instrumentation
Philips PW1729 Powder X-ray diffractometer experiments were
carried out with a PW1050 goniometer (Lelyweg, Netherlands).
Differential scanning calorimetry (DSC) was performed on a
Mettler Toledo FP85 DSC system (Greifense, Sweden). Raman
spectroscopy was carried out on a Thermo-Nicolet NXR FT-Raman
9610 spectrometer (Wisconsin, USA). DRV spectroscopy was per-
formed on a Hewlett-Packard 8453 photodiode Array UV–vis
Spectrophotometer (California, USA) equipped with a Labsphere
RSA-HP-8453 diffuse reﬂectance accessory (Illinois, USA). Hot-
stage microscopy was preformed using a Leica optical microscope
(Wetzlar, Germany) ﬁtted with a Mettler FP52 hot stage apparatus
(Greifense, Switzerland).
Single crystal data for all polymorphs obtained from the Cam-
bridge Crystal Structural Database (CCSD Codes, SFN β SULAMD03
[13] and SFN γ SULAMD02 [14] ) were imputed into the Reﬂex
module of Materials Studio 5.0 software program from Accelrys
(San Diego, USA ) to obtain simulated powder X-ray data and
Miller indices for all reﬂections.
A full description of the DRV spectroscopy methodology can be
found in a previous report by Major, et al. [15].3. Results and discussion
3.1 Preparation and characterization of SFN-β and SFN- γ polymorphs
and SFN-β-TB and SFN-γ-TB
In this study two polymorphs of SFN were examined. The two
polymorphs, SFN-β and SFN-γ studied, are enantiotropically re-
lated and the conversion of SFN-β to SFN-γ can be induced at
elevated temperatures, making them good candidates for ‘real
time’ polymorphic interconversion.
The two polymorphs of SFN (β and γ forms) were prepared and
analyzed using X-ray diffraction and scanning calorimetry. Four
polymorphs of SFN have been recorded, but β and γ are more
accessible. The β form is the most stable form under ambient
conditions.
The experimental and simulated PXRD patterns for SFN-β and
SFN- γ polymorphs are shown in Fig. 1. The PXRD patterns are
different and show deﬁned and sharp peaks which are indicativeof their crystalline nature. Experimental 2theta angles agree
within 70.20° of simulated data conﬁrming polymorphic purity;
however, peak intensities vary signiﬁcantly as a result of preferred
orientation of several atomic planes to incident X-ray beam.
The thermal behaviors of SFN polymorphs were also analyzed.
DSC-thermograms show a single endothermic event for SFN-γ (Tf
¼162.370.3 °C and ΔHf¼146.071.0 J/g) attributed to melting.
However, three endothermic transitions Tf¼128.371.3 °C, ΔHf
¼6.973.0 J/g; Tf¼156.071.3 °C, ΔHf¼1.3370.5 J/g; and Tf
¼162.370.3 °C, ΔHf¼121.073.5 J/g , were observed for SFN-β
attributable to incomplete β-γ transformation, melting of re-
sidual SFN-β and melting of SFN-γ, respectively.
Dye deposition was achieved using drop-wise addition of 1 mL
of methanolic dye solution (200 mg/L) of thymol blue (TB) directly
onto 2 g of solid carefully homogenized using a spatula and dried.
The typical amount of dye adsorbed per gram of solid was 0.1 mg,
which corresponds to the limit of detection of adsorbed dye by the
DRV instrument for most of the investigated polymorphic systems.
Three separate sample preparations and DRV spectroscopic mea-
surements were conducted for each polymorph. SFN-β was always
air-dried as oven-drying sometimes introduced SFN-γ impurity.
Fig. 2. DRV spectra for the calibration samples containing fractional amounts of
dye treated SFN polymorphs. DRV spectra of pure polymorphs are shown as SFN-γ-
TB (1.0γ:0.0β) and SFN-β-TB (0.0γ:1.0β). Inset: calibration plot of F(r)604nm/454nm
versus fractional amounts SFN-γ-TB; r2¼0.99.
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SFN-β to a temperature of 125 °C for 30 min. This heat-induced
transformation method is suitable for SFN-γ, because it is prone to
solvent-induced polymorphic transformation to SFN-β.
The SFN-β-TB and SFN-γ-TB were characterized by PXRD and
DSC to conﬁrm polymorphic form and also to ensure that crys-
talline integrity was maintained after dye treatment. The samples
were screened using sieves to determine particle distribution;
whereby the majority had particle size values greater than
450 μm.
PXRD patterns for SFN-β treated with TB were compared to the
untreated polymorph. Peaks at 2theta values of 10.55, 14.43, 20.57,
21.24 and 22.72 agreed within 70.20° of untreated data. DSC
thermograms of SFN-β-TB samples were also analyzed. Dye trea-
ted samples indicated only two events, i.e., the β-γ transforma-
tion (Tf¼129.070.5 °C and ΔHf¼9.671.0 J/g and the melting of
SFN-β (Tf¼162.470.5 °C and ΔHf¼14371.0 J/g).
PXRD patterns for SFN-γ treated with TB were likewise com-
pared with the untreated polymorph. Peaks at 2theta values of
11.55, 13.43, 19.69, 24.25 and 29.36 agreed within 70.20° of un-
treated data. DSC thermograms of SFN-γ treated with TB were
again compared to the untreated polymorph. A single endothermic
melting was observed for all samples. The onset temperature (Tf)
and enthalpy of fusion (ΔHf) were Tf¼162.670.5 °C and ΔHf
¼144.071.0 J/g for SFN-γ-TB.
3.2 Isothermal kinetic studies of SFN-β transformation monitoring by
DRV
TB is a pH sensitive indicator normally used in solution. It
contains two ionizable groups, i.e., a sulfonic acid group with a pKa
of 1.6 and a phenolic group with a pKa of 8.8. Solution TB can exist
as either a neutral species with a λmax of 547 nm, a mono-anionic
formwith a λmax of 434, or as a di-anionic formwith a λmax of 598.
These forms of TB are clearly distinguishable by ultraviolet spec-
troscopy. SFN possesses two ionizable functional groups, i.e., the
basic phenyl amine group –NH2 (pKa 1.8570.10) and sulfonamide
–SONH2 group which acts as a weak acid (pKa 10.1070.10), which
can play a dominant role in dye deprotonation. The amine group is
a stronger base than the sulfonamide group, so the deprotonation
of dye molecules is greatly inﬂuenced by the surface accessibility
of –NH2. The packing motif for both polymorphs may provide in-
sight into the higher basicity of SFN-γ. The DRV spectra of the
polymorphs of SFN treated with TB indicator are shown in Fig. 2.
SFN-γ-TB absorbs at λmax 454 nm and 604 nm which are in-
dicatives of the yellow mono-deprotonated and blue di-deproto-
nated species of the dye, respectively. Yellow SFN-β-TB absorbs at
454 nm only, suggesting adsorbed mono-anionic TB. Values re-
corded are red shifted to solution values. It appears that the de-
protonation of adsorbed dye molecules is more extensive for SFN-
γ compared to SFN-β, i.e., the proportion of adsorbed TB2 is
greater for SFN-γ, suggesting that SFN-γ has a higher content of
surface basic sites. Details of known solution characteristics of TB
are presented in Table 1. pKa values reported in Table 1 were
obtained using the ACD/I-Lab Web service and agreed with re-
ported literature values at 25 °C.
To establish a relationship between DRV spectroscopic re-
sponse and mole fraction of polymorph transformed, calibration
samples were prepared. Six calibration reference samples were
prepared in the following ratios: 0.0:1.0, 0.2:0.8, 0.4:0.6, 0.6:0.4,
0.8:0.2 and 1.0:0.0 of SFN-γ-TB to SFN-β-TB. These sample mix-
tures were homogenized by shaking in a stoppered bottle. DRV
data were collected for the calibration standards and raw DRV
spectroscopy data were treated by a smoothing algorithm. Spectral
data were analyzed in the range of 400–750 nm and the data
collection time was 5 s.Untreated SFN-β was used as a blank reference for DRV mea-
surements. The DRV spectra for the calibration reference samples
are shown in Fig. 2. Two overlapping bands occur at 454 and
604 nm, and with increasing amounts of SFN-γ-TB, the height of
the 604 nm band increases.
The calibration plot (inset Fig. 2) is based on the ratio of peak
heights (i.e., F(r)604 nm/454 nm) versus fractional amounts of dye
treated SFN-γ-TB. As the peaks were not baseline resolved, the
bands were deconvoluted using the Gaussian curve ﬁtting algo-
rithm before a ratio of peak heights was determined. The plot
reveals a regular relationship between the peak height ratio and
fractional amounts of SFN-γ-TB. This is analogous to the calibra-
tion plot of the ratio of peak heights versus pH for TB in solution.
The data in Fig. 2 suggest that DRV spectra for the calibration
samples containing dye treated SFN polymorphs allow for
differentiation between the two polymorphic forms, and there-
fore, calculation of the amount of SFN-γ-TB converted to SFN-β-TB.
It is, of course, possible to calculate from the ﬁrst-order kinetic
half-life, the amount of starting materials converted to morphed
product and it is therefore possible to quantitatively differentiate
and follow the interconversion of these two forms in ‘real time’.
For ‘real time’ kinetic analysis, eight thin-walled glass vials
were each loaded with 400 mg of SFN-β-TB. The vials were in-
cubated in an oil bath equilibrated at 128 °C at time points of
t¼7.5, 10, 30, 60, 90, 180, 240 and 360 s, upon which the samples
were removed and immediately analyzed by DRV spectroscopy.
At the reaction extremity of t¼360 s, the sample was analyzed
using DSC to ensure complete transformation. DSC data of samples
at t¼360 s compared well with the 1.0:0.0 (SFN-γ-TB: SFN-β-TB)
calibration reference sample.
The DRV spectra (showing two main bands at 454 nm and
604 nm), collected as the transformation proceeded at
12570.5 °C, are shown in Fig. 3.
The β-γ transformation can be readily followed by the
emergence and subsequent increase in the reﬂectance at 604 nm.
The transformation seems to be complete at t¼180 s as the in-
crease in the height of 604 nm band after this time point is not
signiﬁcant. The spectra were deconvoluted using the Gaussian
curve ﬁtting algorithm and peak ratios (F(r)604 nm/454 nm) were
calculated as a fraction converted (α) for each time point using the
calibration plot earlier constructed.
Data were plotted as the fraction of SFN-β transformed
Fig. 3. DRV spectroscopic data for the β-γ transformation in sulfanilamide at
12570.5 °C.
Fig. 4. SFN-β transformed (α/αmax) versus time plot for the β → γ polymorphic
transformation of sulfanilamide at 12570.5 °C. Inset: Linear regression analysis of
the β → γ polymorphic transformation of sulfanilamide at 12570.5 °C.
Table 1
Details of thymol blue (TB) used in this study.
Chemical structure of TB pKa Color and λmaxb of ionization species in solution
1.6a (Sulfonic acid) Red, TBH2, 547 nm
Yellow, TBH- , 434 nm8.870.1 (Phenolic group)
Blue, TB2 , 598 nm
a pKa values were obtained using the ACD/I-Lab Web service and were experimentally veriﬁed.
b Color and λmax of the corresponding ionization species were experimentally determined in buffer indicator solutions at 25 °C covering a range of 1–10 pH units using
KCl/HCl, KHC8H8O4/HCl, KH2PO4/NaOH and Na2HPO4/NaOH buffers. Vis-absorption spectra of buffered indicator solutions were recorded on a Varian-Cary 100 Bio UV–vis
spectrophotometer.
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mation curve that ﬂattens at t¼180 s.
Experimental kinetic data within the range of αt¼7.5–αt¼180(s)
were ﬁtted to sixteen solid-state kinetics models by linear re-
gression analysis. Of the models tried, the ﬁrst-order kinetic model
(Fig. 4) ﬁtted best with a non-negative slope of k¼2.43102 s1
by analytical and graphical inspection.
Analysis of the kinetics of a polymorphic transformation by
more than one kinetic model is common, but in this case, only the
ﬁrst-order kinetic model described the transformation with favor-
able intercepts and R2 value. First-order transformation suggests
that the kinetics was entirely nucleation-controlled and each SFN-β
crystallite within the sample forms only a single SFN-γ nucleus that
grew at a constant rate to transform the entire crystal and hence the
entire sample. This ﬁnding is supported by the hot-stage micro-
scopic observation of β → γ polymorphic transformation in a single
crystal of SFN at 129 °C, in which the observation showed the SFN-γ
initiated at a single nucleation site and then grew as a single crystal
within the SFN-β crystal [11]. Study of the transformation of SFN-β
to SFN-γ in situ using EXRD also by Sheridan et al. [11] suggested
that kinetics is dominated by nucleation, but not entirely nucleation
controlled. Particle size distribution, reaction temperature and the
spectrum collection time employed herein could explain the
differences in the transformation mechanism compared with that
reported by Sheridan et al. [11].
4. Conclusions
This study investigated the development of a novel approach tosurface characterization of drug polymorphism and the extension
of the capabilities of this method to perform ‘real time’ in situ
measurements of pharmaceutical active ingredients. The kinetics
of the polymorphic transformation of SFN polymorphs was
monitored using TB dye and DRV spectroscopy. The thermally-
induced transformation ﬁtted a ﬁrst-order solid-state kinetic
model (R2¼0.992), giving a rate constant of 2.43102 s1. This
technique could be used for in situ measurement to allow
monitoring of drug polymorphic inter-conversion and would be
ideal for the study of rapid phase transformation, as in this study,
the morphological transformation was complete in about 180 s.
We intend to examine the effect of excipients on the UV ab-
sorption and quantitative differentiation of morphological form of
active pharmaceuticals. We expect that, given the opportunity to
avoid overlapping wavelengths from the excipients, we should be
able to extend this research to include the study of morphological
change of drugs in the presence of excipients.References
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